ArticleExperimental dermatology2025

The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5-Independent Manner.

Dorottya Ádám et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.